tranexamic acid has been researched along with Arteriovenous Malformations in 6 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Arteriovenous Malformations: Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated the efficacy of GnRH agonists concomitantly with transient aromatase inhibitor and tranexamic acid to treat women with uterine arteriovenous malformations (AVMs) associated with abnormal uterine bleeding (AUB) to preserve fertility and determine reproductive outcome." | 3.91 | Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid. ( Abu-Rafea, B; Machado, M; Oraif, A; Vilos, AG; Vilos, GA, 2019) |
| "Hereditary hemorrhagic telangiectasia is a rare autosomal dominant inherited disease characterized by vascular dysplasia." | 1.43 | Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report. ( Bloomfield, GS; Kiyeng, JC; Koech, C; Siika, A, 2016) |
| "Severe vaginal bleeding can be the result of cervical arteriovenous malformation, and GnRH agonist may be used for treatment." | 1.32 | A life-threatening event: uterine cervical arteriovenous malformation. ( Amit, A; Deutsch, M; Kerner, H; Lowenstein, L; Solt, I, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fong, MW | 1 |
| Morningstar-Kywi, N | 1 |
| O'Connell, C | 1 |
| Qureshi, U | 1 |
| Han, EE | 1 |
| Vilos, AG | 1 |
| Oraif, A | 1 |
| Machado, M | 1 |
| Abu-Rafea, B | 1 |
| Vilos, GA | 1 |
| Kiyeng, JC | 1 |
| Siika, A | 1 |
| Koech, C | 1 |
| Bloomfield, GS | 1 |
| Hansen, LF | 1 |
| Wewer, V | 1 |
| Pedersen, SA | 1 |
| Matzen, P | 1 |
| Paerregaard, A | 1 |
| Lacout, A | 1 |
| Marcy, PY | 1 |
| El Hajjam, M | 1 |
| Lacombe, P | 1 |
| Lowenstein, L | 1 |
| Solt, I | 1 |
| Deutsch, M | 1 |
| Kerner, H | 1 |
| Amit, A | 1 |
6 other studies available for tranexamic acid and Arteriovenous Malformations
| Article | Year |
|---|---|
Tranexamic Acid in the Treatment of Refractory Gastrointestinal Arteriovenous Malformation Bleeding in Left Ventricular Assist Device Patients.
Topics: Arteriovenous Malformations; Gastrointestinal Hemorrhage; Heart Failure; Heart Ventricles; Heart-Ass | 2022 |
Resolution of Uterine Arteriovenous Malformation and Maintenance of Reproduction in 20 Women Treated with a GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid.
Topics: Abortion, Spontaneous; Adult; Antifibrinolytic Agents; Aromatase Inhibitors; Arteriovenous Fistula; | 2019 |
Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report.
Topics: Antifibrinolytic Agents; Arteriovenous Fistula; Arteriovenous Malformations; Blood Transfusion; Comp | 2016 |
Severe blue rubber bleb nevus syndrome in a neonate.
Topics: Antifibrinolytic Agents; Arteriovenous Malformations; Drug Therapy, Combination; Electrocoagulation; | 2009 |
Tranexamic acid-bevacizumab synergy in HHT patients presenting pulmonary arteriovenous malformations.
Topics: Antibodies, Monoclonal, Humanized; Arteriovenous Malformations; Bevacizumab; Drug Synergism; Humans; | 2012 |
A life-threatening event: uterine cervical arteriovenous malformation.
Topics: Adult; Antifibrinolytic Agents; Arteriovenous Malformations; Brachytherapy; Cervix Uteri; Embolizati | 2004 |